NCT02353078
- Conditions
- Digestive System Diseases, Eosinophilia, Eosinophilic Esophagitis, +10 more
- Locations
-
- Mayo Clinic in Rochester Rochester, Minnesota, United States
Clinical trial condition
Hypersensitivity, Immediate
Explore clinical trials studying Hypersensitivity, Immediate. Study availability and eligibility vary by location and protocol.
6,740 public trials
634 recruiting studies
Hypersensitivity, Immediate trial results
NCT01514760
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- Arkansas Children's Hospital Research Institute Little Rock, Arkansas, United States
Completed
Study of the Ease of Use and Correct Use of Placebo ELLIPTA® Inhaler in Subjects With Asthma
NCT02586506
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- GSK Investigational Site Mobile, Alabama, United States
- GSK Investigational Site Huntington Beach, California, United States
- GSK Investigational Site Aventura, Florida, United States
- GSK Investigational Site Miami, Florida, United States
NCT02164539
- Conditions
- Asthma, Bronchial Diseases, Chronic Disease, +11 more
- Locations
-
- GSK Investigational Site Newport Beach, California, United States
- GSK Investigational Site San Diego, California, United States
- GSK Investigational Site Upland, California, United States
- GSK Investigational Site Sunset, Louisiana, United States
Completed
A Single-Center,Evaluation of the Onset and Duration of Action of AC-170 0.24% Compared to Vehicle
NCT01685242
- Conditions
- Allergic Conjunctivitis, Conjunctival Diseases, Conjunctivitis, +5 more
- Locations
-
- Andover Eye Associates Andover, Massachusetts, United States
NCT02576808
- Conditions
- Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +7 more
- Locations
-
- Thammasat University Hospital Khlong Luang, Changwat Pathum Thani, Thailand
Completed
A Study to Evaluate Efficacy and Safety of ADC3680 in Subjects With Inadequately-Controlled Asthma
NCT01730027
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- Pulmagen Investigational Site Birmingham, Alabama, United States
- Pulmagen Investigational Site Huntington Beach, California, United States
- Pulmagen Investigational Site Riverside, California, United States
- Pulmagen Investigational Site Rolling Hills, California, United States
NCT01573624
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- GSK Investigational Site St Louis, Missouri, United States
- GSK Investigational Site Medford, Oregon, United States
- GSK Investigational Site Orangeburg, South Carolina, United States
- GSK Investigational Site Spartanburg, South Carolina, United States
NCT02958605
- Conditions
- Anaphylaxis, Hypersensitivity, Hypersensitivity, Immediate, +7 more
- Locations
-
- CHU Sainte-Justine Montreal, Quebec, Canada
NCT02739009
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +9 more
- Locations
-
- SGS LSS Clinical Pharmacology Unit Antwerp, Belgium
- St Johns Hospital Budapest, Hungary
- • Arensia Phase I unit Chisinau, Moldova
- Arensia Phase I unit Bucharest, Romania